You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Title |
The efficacy of incretin therapy in patients with type 2 diabetes undergoing hemodialysis
|
---|---|
Published in |
Diabetology & Metabolic Syndrome, February 2013
|
DOI | 10.1186/1758-5996-5-10 |
Pubmed ID | |
Authors |
Yuichi Terawaki, Takashi Nomiyama, Yuko Akehi, Hiromasa Takenoshita, Ryoko Nagaishi, Yoko Tsutsumi, Kunitaka Murase, Hisahiro Nagasako, Nobuya Hamanoue, Kaoru Sugimoto, Ayako Takada, Kenji Ito, Yasuhiro Abe, Yoshie Sasatomi, Satoru Ogahara, Hitoshi Nakashima, Takao Saito, Toshihiko Yanase |
Abstract |
Although incretin therapy is clinically available in patients with type 2 diabetes undergoing hemodialysis, no study has yet examined whether incretin therapy is capable of maintaining glycemic control in this group of patients when switched from insulin therapy. In this study, we examined the efficacy of incretin therapy in patients with insulin-treated type 2 diabetes undergoing hemodialysis. |
Mendeley readers
The data shown below were compiled from readership statistics for 43 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Japan | 1 | 2% |
India | 1 | 2% |
Denmark | 1 | 2% |
Brazil | 1 | 2% |
Unknown | 39 | 91% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 8 | 19% |
Other | 7 | 16% |
Researcher | 6 | 14% |
Student > Ph. D. Student | 5 | 12% |
Student > Bachelor | 4 | 9% |
Other | 7 | 16% |
Unknown | 6 | 14% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 24 | 56% |
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 7% |
Nursing and Health Professions | 2 | 5% |
Engineering | 2 | 5% |
Business, Management and Accounting | 1 | 2% |
Other | 4 | 9% |
Unknown | 7 | 16% |